XML 12 R17.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Stock Options and Grants | 9 Months Ended
--- | ---
Sep. 30, 2013
Stock Options and Grants [Abstract] |
Stock Options and Grants | 10. Stock Options and Grants 2011 Plan – On July 27, 2011, in connection with the Merger, the Company obtained the written consent of holders of a majority of its outstanding common stock approving the 2011 Incentive Stock Plan (the “2011 Plan”). The 2011 Plan covers up to 8,000,000 shares of common stock, and all officers, directors, employees, consultants and advisors are eligible to be granted awards under the 2011 Plan. An incentive stock option may be granted under the 2011 Plan only to a person who, at the time of the grant, is an employee of the Company or its subsidiaries. The 2011 Plan expires on July 26, 2021, and is administered by the Company’s board of directors. As of September 30, 2013, there were 3,928 shares of common stock available for issuance under the 2011 Plan. During 2012, the Company’s board of directors approved the issuance of up to an additional 2,000,000 shares of the Company’s common stock in the form of restricted stock or options. These options generally have the same terms and conditions as those provided under the 2011 Plan, however, the authorization of these options is not subject to shareholder approval. The issuance of these options will be approved by the Company’s board of directors on a case-by-case basis. As of September 30, 2013, there were 76,071 shares of common stock available for issuance under this approval. A summary of stock option activity as of September 30, 2013 and changes during the nine months then ended are presented below: $
|  | Shares |  |  | Weighted Average Fair Value Per Share |  |  | Weighted Average Exercise Price Per Share |  |  | Weighted Average Remaining Terms (in years) |  |  | Aggregate Intrinsic Value |
Outstanding – December 31, 2012 |  |  | 9,317,501 |  |  | $ | 0.11 |  |  | $ | 0.36 |  |  | 9,03 |  |  | 539,650 |
Granted |  |  | 602,500 |  |  |  | 0.09 |  |  |  | 0.40 |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |  |  |
Cancelled |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |  |  |
Outstanding – September 30, 2013 |  |  | 9,920,001 |  |  | $ | 0.11 |  |  | $ | 0.36 |  |  |  | 8.35 |  |  | $ | 162,925 |
Exercisable – December 31, 2012 |  |  | 4,973,333 |  |  | $ | 0.11 |  |  | $ | 0.30 |  |  |  | 8.97 |  |  | $ | 359,600 |
Exercisable – September 30, 2013 |  |  | 6,467,500 |  |  | 0.11 |  |  | $ | 0.36 |  |  |  | 8.32 |  |  | $ | 107,683 |
For the three months and nine months ended September 30, 2013, the Company recognized stock-based compensation expense of $96,209 and $305,517, respectively, which is included in payroll and related expenses in the accompanying condensed consolidated statements of operations. As of September 30, 2013, there was $134,020 of total unrecognized compensation costs related to non-vested stock options, which will be expensed over a weighted average period of 0.41 years. The intrinsic value is calculated as the difference between the fair value as of the balance sheet date and the exercise price of each of the outstanding stock options. The fair value at September 30, 2013 and December 31, 2012 was $0.23 and $0.30 per share, respectively, as determined by using a weighted value between the income approach method and the weighted average bulletin board price. During 2011, the Company executed a two year consulting agreement with a consultant, to act as a Senior Advisor of the Company. In consideration for the services to be performed under the agreement, the Company shall on the last business day of each month during the term, grant the consultant an option to purchase 10,000 shares of the Company’s Common Stock with an exercise price equal to fair market value. One-third of the options vest upon the grant date, the second third vests on the first anniversary date of the grant date, and the remaining third vests on the second anniversary of the grant date. During the nine months ending September 30, 2013, the consultant was granted options to purchase 90,000 shares of the Company’s Common Stock with exercise prices ranging from $0.16 to $0.32 per share. These options were not granted under the 2011 Plan. The fair value of these options upon issuance amounted to $13,828. On March 14, 2013, under the 2011 Plan, three employees and directors of the Company were granted options to purchase 150,000 shares of the Company’s Common Stock with an exercise price of $0.43 per share. One-third of the options vest upon the grant date, the second third vests on the first anniversary date of the grant date, and the remaining third vests on the second anniversary of the grant date. The fair value of these options upon issuance amounted to $11,310. On March 14, 2013, seven employees and directors of the Company were granted options to purchase 362,500 shares of the Company’s Common Stock with an exercise price of $0.43 per share. These options were granted separate and apart from the 2011 Plan and were not granted from the shares available under the Company’s 2011 Plan. One-third of the options vest upon the grant date, the second third vests on the first anniversary date of the grant date, and the remaining third vests on the second anniversary of the grant date. The fair value of these options upon issuance amounted to $27,333. The fair value of the stock-based option awards granted during the nine months ended September 30, 2013 were estimated at the date of grant using the Black-Scholes option valuation model with the following assumptions:
Stock price |  | $ | 0.23-0.24 |
Expected dividend yield |  |  | 0.00 | %
Expected stock volatility |  |  | 50 | %
Risk-free interest rate |  |  | 0.88-2.78 | %
Expected life |  | 5.5 - 10 years |
Because the Company does not have significant historical data on employee exercise behavior, the Company uses the “Simplified Method” to calculate the expected life of the stock-based option awards. The simplified method is calculated by averaging the vesting period and contractual term of the options.

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration